As of Dec 15
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Achieve Life Sciences Inc have a median target of 0.90, with a high estimate of 0.90 and a low estimate of 0.90. The median estimate represents a -23.73% decrease from the last price of 1.18.
The current consensus among 1 polled investment analysts is to Hold stock in Achieve Life Sciences Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.